EMICIZUMAB
UNII 7NL2E3F6K3

Substance Identification & Data

This profile provides standardized clinical and technical data for Emicizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7NL2E3F6K3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610943-06-0 and the RxNorm Concept ID (RxCUI) 1989794. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7NL2E3F6K3

CAS Registry Number

1610943-06-0

RxNorm Concept ID

1989794

Detailed Substance Profile

Preferred Name

EMICIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

7NL2E3F6K3

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C159541

National Cancer Institute reference terminology for clinical and research data.

INN ID

10115

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-03

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emicizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMICIZUMAB

EMICIZUMAB-KXWH

Common Names & Synonyms

EMICIZUMAB [INN]

EMICIZUMAB [JAN]

EMICIZUMAB [MI]

EMICIZUMAB [USAN]

EMICIZUMAB [WHO-DD]

EMICIZUMAB KXWH [WHO-DD]

EMICIZUMAB-KXWH [PURPLE BOOK CDER]

IMMUNOGLOBULIN G4-KAPPA, BISPECIFIC, ANTI-(HOMO SAPIENS F9A (ACTIVATED COAGULATION FACTOR F9, ACTIVATED COAGULATION FACTOR IX) AND ANTI-(HOMO SAPIENS F10 (COAGULATION FACTOR 10, COAGULATION FACTOR X)), HUMANIZED MONOCLONAL ANTIBODY